Vitrosens Biotechnology is a high-tech manufacturing facility in Turkey which integrated R&D, production, and sales. The seeds of the company were planted in 2016. Since then, it becomes a reliable manufacturer of the rapid diagnostic test kits, recently COVID-19 products launched.
Our manufacturing center, located in Istanbul, Turkey, is a rapidly growing manufacturing center for IVD (in-vitro-diagnostic) products and new product development. Vitrosens Biotechnology has established a comprehensive Quality Management System that applies international standards (EN ISO 13485), ensuring top quality test results and accuracy.
Also, most of our products are CE certified. Vitrosens Biotechnology is one of the leading Turkish manufacturers of COVID-19 Rapid Test Kit sold in Europe. Vitrosens Biotechnology also focuses on investment in new product development.
Most of our R&D team members have more than 5 years of experience in POCT (Point of Care Testing) product development, they have already successfully optimized our products and they are working on new product development intelligently and efficiently. Our cost-effective lateral flow test kits play an important role in point-of-care diagnosis for COVID-19 pandemic.
Vitrosens Biotechnology aims to provide the world with high-quality lateral flow IVD test products. Our cost-effective lateral flow test kits enable healthcare professionals and individuals to-operate rapid test cassettes easily for fast and effective COVID-19 diagnosis.
Our well-developed lateral flow cassette OEM (Original Equipment Manufacturer), ODM (Original Design Manufacturer), and private labeling services can help medical device distributors to commercialize the most tailored IVD products.
If you have any unique requirements about COVID-19 products, please feel free to contact us. Our dedicated team will do our best to ensure that your needs are met.
Our History Time Line
Lateral Flow IVD Test Kit R&D started. In this process, university and private sector collaborations were made.
Food Safety, Animal Health and Medical Products have been completed.